Cetaphil Owner Galderma Sales Lift 9.2% on Strong Skincare and Injectable Demand
In the first nine months of the year, the Swiss beauty firm saw its sales rise to $3.26 billion thanks to robust performance in Europe and gains in China and Latin America.